American Oncology Network, Inc. - AONC Future Profit

AONC (American Oncology Network Inc) - company brandmark

Projected revenue and profit reflect the dynamics of the American Oncology Network (AONC) center network, which is shielded from expansion by tech giants through unified IT compliance and direct insurance contracts. High authority among physicians confirms the ethics and reliability of AONC operational standards. The value of shows the current volume of the metric, highlighting the company's pricing power, which maintains margins above market levels due to procurement scale.

AONC: American Oncology Network Future Profit 07/04/2022 - 11/18/2026

American Oncology Network Inc - analytical breakdowns and key metrics (AONC)

- price and consensus price forecast:
Fundamental company analysis:aoncology.com, AONC
Core merchandise of American Oncology Network, Inc.

The regional market consolidation strategy of American Oncology Network (AONC) requires precise monitoring of acquisition efficiency. The company's forward earnings aggregate current analyst expectations, filling the gaps between infrequent reports. This indicator's trend reflects the market consensus regarding the business's future profitability. Growth in this metric confirms the successful integration of new practices into a unified IT system. An overly smooth trend line may signal overestimated forecast stability.

Main competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Expected Net Income|Projected Future Earnings XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Expected Net Profit|PPBT: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit